Efficacy Outcome Measures of Oral Ponesimod Compared to Teriflunomide in Patients with Relapsing Multiple Sclerosis: Results of the Randomized, Active-Controlled, Double-Blind, Parallel-Group Phase 3 OPTIMUM Study

被引：0
|
作者：
Fox, Robert [1 ]
Kappos, Ludwig [2 ,3 ,4 ,5 ]
Burcklen, Michel [6 ]
Freedman, Mark [7 ,8 ]
Havrdova, Eva [9 ]
Hennessy, Brian [6 ]
Hohlfeld, Reinhard [10 ]
Lublin, Fred [11 ]
Montalban, Xavier [12 ,13 ]
Pozzilli, Carlo [14 ]
Scherz, Tatiana [6 ]
Linscheid, Philippe [6 ]
Pirozek-Lawniczek, Magdalena [6 ]
Kracker, Hilke [6 ]
Sprenger, Till [2 ,3 ,4 ,5 ,15 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Univ Hosp Basel, Neurol Clin & Policlin, Dept Med, Basel, Switzerland
[3] Univ Hosp Basel, Neurol Clin & Policlin, Dept Clin Res, Basel, Switzerland
[4] Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed, Basel, Switzerland
[5] Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed Engn, Basel, Switzerland
[6] Actel Pharmaceut Ltd, Allschwil, Switzerland
[7] Univ Ottawa, Ottawa, ON, Canada
[8] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[9] Charles Univ Prague, Prague, Czech Republic
[10] Ludwig Maximilians Univ Munchen, Inst Clin Neuroimmunol, Munich, Germany
[11] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[12] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada
[13] Vall dHebron Univ Hosp, Multiple Sclerosis Ctr Catalonia, Barcelona, Spain
[14] Sapienza Univ Rome, S Andrea MS Ctr, Rome, Italy
[15] DKD HELIOS Klin Wiesbaden, Wiesbaden, Germany
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
3972
引用
收藏
页数：5
相关论文
共 50 条
  • [41] A randomized, double-blind, parallel-group, placebo-controlled Phase 3 trial to evaluate efficacy and safety of ocrelizumab in PPMS
    Montalban, Xavier
    Hemmer, Bernhard
    Rammohan, Kottil W.
    Giovannoni, Gavin
    De Seze, Jerome
    Bar-Or, Amit
    Arnold, Douglas L.
    Sauter, Annette
    Masterman, Donna
    Fontoura, Paulo
    Chin, Peter
    Garren, Hideki
    Wolinsky, Jerry S.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 17 - 17
  • [42] GLANCE: A double-blind, randomized, placebo-controlled, parallel-group safety study of natalizumab in combination with glatiramer acetate in subjects with relapsing-remitting multiple sclerosis
    Goodman, AD
    Rossman, HS
    Bar-Or, A
    Miller, A
    Miller, D
    Lublin, F
    Khan, O
    Metz, L
    Panzara, M
    Yang, MH
    Toal, M
    Sandrock, A
    NEUROLOGY, 2005, 64 (06) : A277 - A278
  • [43] Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study
    Li, Yanpeng
    Zhang, Ruoxi
    Zhou, Yanling
    Bao, Cungang
    Lin, Zhaocun
    Chen, Chunyan
    He, Jingjing
    Jin, Zhiping
    Song, Lihua
    Zhang, Min
    Guo, Sigen
    Jiang, Yu
    Zhao, Zhongxin
    SLEEP, 2024, 47 (02)
  • [44] Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study
    Inoue, Yuichi
    Shimizu, Tetsuo
    Hirata, Koichi
    Uchimura, Naohisa
    Ishigooka, Jun
    Oka, Yasunori
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    SLEEP MEDICINE, 2013, 14 (11) : 1085 - 1091
  • [45] Efficacy of resveratrol in the treatment of unipolar depression: double-blind randomized placebo-controlled parallel-group study
    Aftanas, L. I.
    Markov, A. A.
    Rikita, M. V.
    Danilenko, K. V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S189 - S189
  • [46] Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: A randomized, prospective, parallel-group, double-blind, placebo-controlled study
    Loder, E
    Silberstein, SD
    Abu-Shakra, S
    Mueller, L
    Smith, T
    HEADACHE, 2004, 44 (02): : 120 - 130
  • [47] Efficacy and Safety of Tabalumab in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
    Silk, Maria
    Nantz, Eric
    NEUROLOGY, 2018, 90
  • [48] Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study
    Ueberall, Michael A.
    Mueller-Schwefe, Gerhard H. H.
    Terhaag, Bernd
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (10) : 1617 - 1634
  • [49] Randomised, double-blind, parallel-group, dose-comparison study of glatiramer acetate in relapsing-remitting multiple sclerosis
    Cohen, J.
    Rovaris, M.
    Goodman, A.
    Wynn, D. R.
    Ladkani, D.
    Filippi, M.
    MULTIPLE SCLEROSIS, 2006, 12 : S99 - S100
  • [50] Prevention of Recurrence of Gastric and Duodenal Ulcers by Rabeprazole in Patients Taking Low-Dose Aspirin - A Phase 2/3, Randomized, Parallel-Group, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Study
    Watanabe, Toshio
    Higuchi, Kazuhide
    Kato, Mototsugu
    Fujishiro, Mitsuhiro
    Kinoshita, Yoshikazu
    Iwakiri, Ryuichi
    Umegaki, Eiji
    Sugisaki, Nobuyuki
    Okada, Yasushi
    Ogawa, Hisao
    Arakawa, Tetsuo
    Fujimoto, Kazuma
    GASTROENTEROLOGY, 2014, 146 (05) : S183 - S184
12345